PELVIC EXENTERATION FOR LOCALLY ADVANCED COLORECTAL-CARCINOMA
PELVIC EXENTERATION FOR LOCALLY ADVANCED COLORECTAL-CARCINOMA
复制标题
DOI：
10.1097/00000658-198204000-00022
复制
发表时间：
1982-01-01
影响因子：
9
通讯作者：
ONG, GB
中科院分区：
文献类型：
--
作者：
BOEY, J;WONG, J;ONG, GB
49例下结肠癌或直肠癌浸润邻近盆腔脏器的患者行盆腔脏器清除术，5年累积生存率为38.8%。全脏器切除术或后脏器切除术后的生存率和无病期无显著差异。疾病的阶段是结果的主要决定因素; 5年生存率平均为51.8%和28.8%的II期和III期，分别。全脏器切除术后的住院死亡率（26.9%）主要是由于技术事故，以及纳入了许多高危但有症状的老年患者。局部晚期结直肠癌的盆腔清除术完全适用于健康的患者，尤其是II期患者。
Pelvic exenteration provided worthwhile palliation and achieved a cumulative 5 yr survival rate of 38.8% in 49 patients who had carcinoma of the lower colon or rectum infiltrating adjoining pelvic viscera. Survival and the disease-free period were not significantly different after total or posterior exenteration. The stage of disease was the major determinant of outcome; 5 yr survival rates averaged 51.8% and 28.8% for Stages II and III, respectively. Hospital mortality (26.9%) after total exenteration was chiefly due to technical mishaps, and the inclusion of many high-risk but symptomatic elderly patients. Complete clearance of locally advanced colorectal cancer by pelvic exenteration is indicated in fit patients, especially those with Stage II disease.